| 标题 |
Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension |
| 网址 | |
| DOI | |
| 其它 |
期刊:Diabetes Research and Clinical Practice 作者:Jun Sung Moon; Kyung-Ah Han; Jae Myung Yu; Jong Chul Won; Jun Goo Kang; et al 出版日期:2026 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)